Ignite Creation Date:
2025-12-24 @ 2:10 PM
Ignite Modification Date:
2026-01-18 @ 6:23 PM
Study NCT ID:
NCT00641095
Status:
COMPLETED
Last Update Posted:
2018-10-31
First Post:
2008-03-20
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase III, Multicentre, Randomised Study of Fludarabine/Cyclophosphamide Combination With or Without Rituximab in Patients With Untreated Mantle Cell Lymphoma
Sponsor:
University College, London
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2006-12-07
Start Date Type:
ACTUAL
Primary Completion Date:
2011-11-23
Primary Completion Date Type:
ACTUAL
Completion Date:
2015-05-22
Completion Date Type:
ACTUAL
First Submit Date:
2008-03-20
First Submit QC Date:
None
Study First Post Date:
2008-03-21
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-10-29
Last Update Post Date:
2018-10-31
Last Update Post Date Type:
ACTUAL